| Product Name | MF | CAS | Details |
|---|
| Ilaprazole sodium hydrate | C19H21N4NaO3S | 2322264-11-7 | Details |
| MuRF1-IN-2 | C23H22N2O7 | 937891-74-2 | Details |
| Ac-Exatecan | C26H24FN3O5 | 2922852-48-8 | Details |
| E235 | C28H25FN4OS | 891894-69-2 | Details |
| Amine-PEG3-Lys(PEG3-N3)-PEG3-N3 | C30H58N10O12 | 2244602-35-3 | Details |
| MC-VA-PAB-Exatecan | C50H54FN7O11 | 2680543-57-9 | Details |
| BODIPY FL thalidomide | 2740620-18-0 | Details |
| Lepzacitinib | 2321488-47-3 | Details |
| CYP11A1-IN-1 | 2744168-51-0 | Details |
| S07-1066 | 876625-29-5 | Details |
| PU-48 | C14H12N2O3S | 335394-78-0 | Details |
| Aβ/tau aggregation-IN-3 | C23H22N4O3 | 1210750-32-5 | Details |
| U-89843A | C16H24ClN5 | 157013-85-9 | Details |
| PDE7-IN-3 | C18H21ClN2O4 | 908570-13-8 | Details |
| Dihydro-5-azacytidine acetate | 2470972-18-8 | Details |
| EGFR-IN-85 | C26H30N8O2 | 1956378-29-2 | Details |
| Anti-amyloid agent-1 | C21H17F3N2O3 | 1396778-73-6 | Details |
| M62812 free base | C13H11N3OS | 613262-61-6 | Details |
| GBT1118 | C19H20N2O4 | 1628799-51-8 | Details |
| IL-1β-IN-2 | 2242896-76-8 | Details |
| Nrf2 activator-7 | 2456295-39-7 | Details |
| TH-Z835 | C30H38N6O | 2766209-50-9 | Details |
| Smurf1-IN-1 | 1824708-03-3 | Details |
| Dim16 | 2743448-32-8 | Details |
| Z-LLF-CHO | C29H39N3O5 | 133429-58-0 | Details |
| hnNOS-IN-2 | 2700326-00-5 | Details |
| SJ1461 | 2924546-70-1 | Details |
| LTB4 antagonist 2 | 2929239-85-8 | Details |
| LTB4 antagonist 3 | 2929239-87-0 | Details |
| IDO1-IN-21 | 2892432-98-1 | Details |
| SLC26A3-IN-3 | C20H17IO5 | 2369983-43-5 | Details |
| Chitin synthase inhibitor 14 | 2922114-19-8 | Details |
| HDAC-IN-58 | C16H13ClF2N4O3S | 2071224-39-8 | Details |
| MmpL3-IN-3 | 1639438-67-7 | Details |
| DNA gyrase B-IN-3 | 2412834-56-9 | Details |
| YIAD-0205 | 2446054-34-6 | Details |
| HIF-2α-IN-9 | 2648334-36-3 | Details |
| BC-05 | 2260717-73-3 | Details |
| NS2B/NS3-IN-3 hydrochloride | 2832876-91-0 | Details |
| AMX12006 | 2639775-01-0 | Details |
| Antitubercular agent-37 | C22H22N8O2 | 21696-12-8 | Details |
| MAO-B-IN-23 | C19H18BrNO | 2107978-22-1 | Details |
| LSD1-UM-109 | 2252446-26-5 | Details |
| Keap1-Nrf2-IN-15 | 2456295-45-5 | Details |
| SIRT5 inhibitor 6 | 2834736-82-0 | Details |
| AJH-836 | 388621-67-8 | Details |
| Xilmenolone | C26H37N3O2 | 2368807-26-3 | Details |
| J-1048 | 2374772-60-6 | Details |
| HPK1-IN-35 | 2935903-77-6 | Details |
| MMP13-IN-4 | C21H17BrN4O5 | 514855-02-8 | Details |
| SARS-CoV-2 nsp14-IN-3 | 2920574-16-7 | Details |
| ZINC475239213 | 2871002-89-8 | Details |
| SRI 6409-94 | C24H29NO3 | 127697-58-9 | Details |
| (R)-Azasetron besylate | C17H20ClN3O3.C6H6O3S | 2025360-91-0 | Details |
| Erythronic acid | C4H8O5 | 13752-84-6 | Details |
| NLRP3-IN-17 | 2254432-75-0 | Details |
| Tubulin inhibitor 33 | 2944462-67-1 | Details |
| BChE/HDAC6-IN-1 | 2925457-27-6 | Details |
| CDK/HDAC-IN-3 | 2944087-54-9 | Details |
| NNRTIs-IN-1 | 2925364-09-4 | Details |
| SIRT5 inhibitor 7 | 2951090-00-7 | Details |
| BRD4 Inhibitor-28 | 2468960-80-5 | Details |
| OPC-163493 | C14H8F3N5S | 1644467-84-4 | Details |
| SHP2-IN-13 | 2951854-02-5 | Details |
| Neuraminidase-IN-13 | 2222067-23-2 | Details |
| Yhhu6669 | 2569526-80-1 | Details |
| HIV-1 protease-IN-8 | 2925287-55-2 | Details |
| MY-673 | 2944459-96-3 | Details |
| Leramistat | C20H21ClN2O3S | 1642602-54-7 | Details |
| Anticancer agent 164 | 2235393-30-1 | Details |
| SHP2-IN-5 | C12H8O6 | 54755-93-0 | Details |
| Pomalidomide-5-C10-NH2 hydrochloride | 2863635-00-9 | Details |
| TWIK-1/TREK-1-IN-1 | 1440532-30-8 | Details |
| SIKs-IN-1 | 2927557-06-8 | Details |
| TWIK-1/TREK-1-IN-2 | C20H29F3N2O2 | 1440532-32-0 | Details |
| HDAC-IN-63 | 2920046-95-1 | Details |
| S-F24 | 2946669-78-7 | Details |
| Antileishmanial agent-14 | 1638956-72-5 | Details |
| WU-04 | 2921711-74-0 | Details |
| Aurora Kinases-IN-4 | 2877011-84-0 | Details |
| α-Synuclein inhibitor 9 | C27H24O4 | 1510825-03-2 | Details |
| ATR-IN-23 | 2923800-62-6 | Details |
| Antimalarial agent 26 | C20H22N4O3 | 2299199-56-5 | Details |
| CS640 | C21H31N7O | 2388506-83-8 | Details |
| HIV-1 inhibitor-57 | 2745197-24-2 | Details |
| A-77636 | C20H27NO3 | 778546-51-3 | Details |
| NLRP3-IN-21 | 2956791-61-8 | Details |
| Quorum Sensing-IN-2 | 2925926-80-1 | Details |
| Thalidomide-NH-C10-NH2 hydrochloride | 2460022-53-9 | Details |
| EGFR-IN-82 | 2568086-81-5 | Details |
| BTM-3528 | C24H19F4N3O2S2 | 2054998-45-5 | Details |
| Anticancer agent 110 | C18H13FN6OS | 887349-03-3 | Details |
| EP12 | 2882916-73-4 | Details |
| JNJ-1013 | 2597343-08-1 | Details |
| SDH-IN-5 | 2922765-95-3 | Details |
| Antimalarial agent 24 | C20H16N4O2 | 2299199-54-3 | Details |
| RET-IN-22 | C29H31F3N6O4 | 2918281-79-3 | Details |
| (R)-VX-11e | C24H20Cl2FN5O2 | 1680187-43-2 | Details |
| CK2-IN-9 | C23H29N9O | 1461658-58-1 | Details |
| Product Total： Product Page： | ||||
| 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 | ||||